Case: Novartis

Merck and Novartis gender bias suits draw renewed attention, and New York is taking action

June 28th, 2018

by Angus Liu As the #MeToo movement puts workplace sexual harassment at the front, Merck & Co. and Novartis, two of the largest pharma companies, find themselves entangled in a different kind of gender problem: alleged pregnancy discrimination. Merck for years has been embroiled in a lawsuit that accused it of discriminating against female sales […]

Read More

New York to Investigate Claims of Pregnancy Discrimination at 4 Companies

June 27th, 2018

By Natalie Kitroeff Gov. Andrew M. Cuomo of New York directed a state agency on Wednesday to investigate allegations of pregnancy discrimination at Walmart, Merck, Novartis and Glencore. Mr. Cuomo said the agency, the Division of Human Rights, also planned to run ads on New York City subways to raise awareness about pregnancy discrimination. The […]

Read More

Approval Seen for Novartis Gender-Discrimination Pact

November 9th, 2010

As it appeared in the Wall Street Journal By CHAD BRAY NEW YORK—A federal judge said Friday that she will likely approve a $175 million settlement of a closely watched gender-discrimination lawsuit involving Novartis AG’s U.S. unit and its female sales force. At a hearing Friday, U.S. District Judge Colleen McMahon in Manhattan said she […]

Read More

Novartis Agrees to Pay $152.5 Million to Settle Historic Gender Discrimination Class Action

July 15th, 2010

As it appeared in Litigation Daily David Sanford and Katherine Kimpel of Sanford, Wittels & Heisler told us in May that they were confident their historic $250 million punitive damages verdict in a gender discrimination class action against Novartis would be upheld by the U.S Court of Appeals for the Second Circuit. That may be […]

Read More

Novartis, Female Sales Reps to Settle Sex Bias Class Action for $175 Million

July 15th, 2010

As it appeared in Bloomberg A federal district court in New York July 14 granted preliminary approval to a $175 million agreement between Novartis Pharmaceuticals Corp. and a nationwide class of female current and former sales employees to settle claims of systemic sex bias in pay, promotions, and pregnancy leave (Velez v. Novartis Pharm. Corp., […]

Read More

Novartis Unit Settles Gender Suit for About $175 Million

July 14th, 2010

As it appeared in the Wall Street Journal By CHAD BRAY NEW YORK—Novartis AG’s U.S. unit has agreed to settle a closely watched gender discrimination lawsuit involving its female sales force for as much as $175 million, the drug maker said Wednesday. The settlement, which is subject to court approval, resolves a long-running case that […]

Read More

Novartis agrees to pay $152.5 million for gender discrimination claims

July 14th, 2010

As it appeared in the Associated Press NEW YORK (AP) — Novartis has agreed to pay $152.5 million to settle claims that it discriminated against women by paying them less than men. The settlement was announced Wednesday by the pharmaceutical company and lawyers for the plaintiffs. It calls for an additional $22.5 million to be […]

Read More

Novartis to Pay Millions for Sex Discrimination

May 20th, 2010

As it appeared in the Swiss Broadcasting Corporation The Basel-based pharmaceutical company Novartis has been fined $250 million (SFr289 million) in punitive damages after a New York jury found it guilty of practicing sex discrimination. The damages are to be divided between about 5,600 women employees of the Novartis Pharmaceuticals Corporation, a United States affiliate […]

Read More

Novartis Hit With $250 Million in Punitives in Gender Bias Case

May 20th, 2010

As it appeared in the New York Law Journal Mark Hamblett, New York Law Journal Novartis Pharmaceuticals was slammed with $250 million in punitive damages on Wednesday in the largest-ever award in a gender bias case. A New York federal jury took slightly more than one day of deliberations to deliver the blow after finding […]

Read More

Novartis and Its Lawyers Just Don’t Get It

May 20th, 2010

As appeared in the American Lawyer Susan Beck What was Novartis thinking? On Wednesday a Manhattan federal district court jury came back with a stunning award of $250 million in punitive damages against the U.S. subsidiary of the Swiss pharmaceutical giant for discriminating against women in its sales force–the largest verdict ever in a gender […]

Read More
Back to Top